HAMED KAMAL (Chief Medical Officer) received a stock award from SPERO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/14/2023ACC: 0000950170-23-027860
Officer· Chief Medical Officer
Since Sep 2022
+140K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
140K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+140K
Price / share
—
Trade value
—
% of position
29.4%
6/12/2023
475.96K→615.96K
Total
Net shares
+140K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2023 | A · Award | +140K | — | — | 29.4% | 475.96K | 615.96K |
| Total | +140K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported